Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.

Thyroid : official journal of the American Thyroid Association - 1 Jun 2018

He Huiling, Li Wei, Yan Pearlly, Bundschuh Ralf, Killian Jackson A, Labanowska Jadwiga, Brock Pamela, Shen Rulong, Heerema Nyla A, de la Chapelle Albert

Abstract excerpt

BACKGROUND: The BRAFV600E mutation is the most common driver in papillary thyroid carcinoma (PTC) tumors. In recent years, gene fusions have also been recognized as important drivers of cancer in PTC. Previous studies have suggested that thyroid tumors with fusion genes frequently display an aggressive course. These observations prompted further exploration of gene fusions in PTC tumors. The aim was to search for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to LIM Domain Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to NIH 3T3 Cells

Share to Oncogene Proteins, Fusion

Share to Sequence Analysis, RNA

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 29768105
DOI: 10.1089/thy.2017.0258
PMCID: PMC5994666

Genes

BRAF
LMO7
CCDC6
RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.PMID 29768105Read ↗

Descriptive Analysis of Common Fusion Mutations in Papillary Thyroid Carcinoma in Hungary.Semantic proximity Read ↗

Targeted next generation sequencing identifies somatic mutations and gene fusions in papillary thyroid carcinoma.Semantic proximity Read ↗

Gene Fusions in Thyroid CancerSemantic proximity Read ↗

RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.Semantic proximity Read ↗

Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis.Semantic proximity Read ↗

ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult populationSemantic proximity Read ↗

NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on PrognosisSemantic proximity Read ↗

RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.Semantic proximity Read ↗

A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions.Semantic proximity Read ↗

Multifocal Papillary Thyroid Carcinomas With Discordant Molecular Drivers: Emphasizing the Morphology and Collision Tumors.Semantic proximity Read ↗

BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma.Semantic proximity Read ↗

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.